Bone mineral density and body composition in lean women with polycystic ovary syndrome

Fertility and Sterility

Volumn 72, Issue 1, 1999, Pages 21-25

  Good, Candace ^a   Tulchinsky, Mark ^a   Mauger, David ^a   Demers, Laurence M ^a   Legro, Richard S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Amenorrhea; Body composition; Bone density; Densitometry; Hyperandrogenism

Indexed keywords

ANDROGEN; GLUCOSE; INSULIN; TESTOSTERONE;

ADULT; AMENORRHEA; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BONE DENSITY; BONE MINERALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

EID: 0033168297     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00203-4     Document Type: Article

References (29)

1. Knochenhauer E.S., Key T.J., Kahsar-Miller M., Waggoner W., Boots L.R., Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 83:1998;3078-3082.
2. Dixon J.E., Rodin A., Murby B., Chapman M.G., Fogelman I. Bone mass in hirsute women with androgen excess. Clin Endocrinol (Oxf). 30:1989;271-277.
3. Dagogo-Jack S., al-Ali N., Qurttom M. Augmentation of bone mineral density in hirsute women. J Clin Endocrinol Metab. 82:1997;2821-2825.
4. Simberg N., Tiitinen A., Silfvast A., Viinikka L., Ylikorkala O. High bone density in hyperandrogenic women effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement . J Clin Endocrinol Metab. 81:1996;646-651.
5. Di Carlo C., Shoham Z., MacDougall J., Patel A., Hall M.L., Jacobs H.S. Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil Steril. 57:1992;314-319.
6. Rebuffe-Scrive M., Cullberg G., Lundberg P.A., Lindstedt G., Bjorntorp P. Anthropometric variables and metabolism in polycystic ovarian disease. Horm Metab Res. 21:1989;391-397.
7. Douchi T., Ijuin H., Nakamura S., Oki T., Yamamoto S., Nagata Y. Body fat distribution in women with polycystic ovary syndrome. Obstet Gynecol. 86:1995;516-519.
8. Dumesic D.A., Abbott D.H., Eisner J.R., Herrmann R.R., Reed J.E., Welch T.J., et al. Pituitary desensitization to gonadotropin-releasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women. Fertil Steril. 70:1998;94-101.
9. Ferretti J.L., Capozza R.F., Cointry G.R., Garcia S.L., Plotkin H., Alvarez Filgueira M.L., et al. Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age. Bone. 22:1998;683-690.
10. Kley H.K., Edelmann P., Kruskemper H.L. Relationship of plasma sex hormones to different parameters of obesity in male subjects. Metabolism. 29:1980;1041-1045.
11. Lobo R.A., Granger L., Goebelsmann U., Mishell D.R. Jr. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab. 52:1981;156-158.
12. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes. 20:1996;291-302.
13. Wild R.A. Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. 98:1995;27S-32S.
14. Dunaif A., Segal K.R., Futterweit W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1989;1165-1174.
15. Legro R.S., Finegood D., Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 83:1998;2694-2698.
16. Dunaif A., Scott D., Finegood D., Quintana B., Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab. 81:1996;3299-3306.
17. Kellie S.E. Measurement of bone density with dual-energy x-ray absorptiometry (DEXA). J Am Med Assoc. 267:1992;286-294.
18. Blake G.M., Fogelman I. Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med. 27:1997;210-228.
19. Adami S., Zamberlan N., Castello R., Tosi F., Gatti D., Moghetti P. Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women. Clin Endocrinol (Oxf). 48:1998;169-173.
20. Horber F.F., Gruber B., Thomi F., Jensen E.X., Jaeger P. Effect of sex and age on bone mass, body composition and fuel metabolism in humans. Nutrition. 13:1997;524-534.
21. Wang M.C., Aguirre M., Bhudhikanok G.S., Kendall C.G., Kirsch S., Marcus R., et al. Bone mass and hip axis length in healthy Asian, black, Hispanic, and white American youths. J Bone Miner Res. 12:1997;1922-1935.
22. Seeman E., Hopper J.L. Genetic and environmental components of the population variance in bone density. Osteopor Int. 7:(Suppl 3):1997;S10-S16.
23. Colvard D.S., Eriksen E.F., Keeting P.E., Wilson E.M., Lubahn D.B., French F.S., et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA. 86:1989;854-857.
24. Lieberherr M., Grosse B. Androgens increase intracellular calcium concentration and inositol 1,4,5-triphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem. 269:1994;7217-7223.
25. Prezelj J., Kocijancic A. Antiandrogen treatment with spironolactone and linestrenol decreases bone mineral density in eumenorrhoeic women with androgen excess. Horm Metab Res. 26:1994;46-48.
26. Mullis P.E., Yoshimura N., Kuhlmann B., Lippuner K., Jaeger P., Harada H. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood . J Clin Endocrinol Metab. 82:1997;1739-1745.
27. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 80:1995;3689-3698.
28. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med. 337:1997;91-95.
29. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331:1994;1056-1061.